Pradaxa, whose generic name is dabigatran etexilate, is an anticoagulant medication used to prevent blood clots in individuals with certain medical conditions. It belongs to a class of drugs called direct thrombin inhibitors.
Dosage:
The recommended dosage of Pradaxa is 110mg taken orally twice daily. It is important to follow the prescribed dosing schedule provided by your healthcare provider. Each dose should be taken approximately 12 hours apart. The capsules should be swallowed whole with a glass of water and can be taken with or without food.
Usage:
Pradaxa is primarily prescribed for the following conditions:
- Stroke prevention in atrial fibrillation: Atrial fibrillation is an irregular heart rhythm that increases the risk of blood clots forming in the heart. Pradaxa is commonly used to reduce the risk of stroke and systemic embolism in individuals with atrial fibrillation.
- Treatment and prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE): DVT occurs when blood clots form in the deep veins, usually in the legs. PE occurs when these clots break loose and travel to the lungs. Pradaxa may be prescribed for the initial treatment and prevention of recurrent DVT and PE.
It is essential to take Pradaxa exactly as prescribed. Missing doses or taking more than the recommended dosage can increase the risk of bleeding or decrease the effectiveness of the medication. If you accidentally miss a dose, take it as soon as you remember, unless it is close to the time for your next scheduled dose. In that case, skip the missed dose and continue with your regular dosing schedule.
It is important to note that Pradaxa is a potent anticoagulant, which means it can increase the risk of bleeding. Contact your healthcare provider immediately if you experience any signs of bleeding, such as unusual bruising, nosebleeds, bleeding gums, or prolonged bleeding from cuts. Also, inform your healthcare provider about any medications or supplements you are taking, as some may interact with Pradaxa and affect its effectiveness or increase the risk of bleeding.
Pradaxa should not be stopped or changed without consulting your healthcare provider, as abrupt discontinuation can increase the risk of blood clots. If you need to stop Pradaxa for any reason, your healthcare provider will provide specific instructions to ensure a safe transition.
In summary, Pradaxa is an anticoagulant medication used to prevent blood clots in individuals with atrial fibrillation, deep vein thrombosis, and pulmonary embolism. Following the prescribed dosage and usage instructions, as well as promptly reporting any signs of bleeding, is crucial for safe and effective use of Pradaxa.